NIVESTYM
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for NIVESTYM, covering 2018-07-20 to 2024-02-16. Get the full timeline:
Most recent: FDA Approved: NIVESTYM — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)